Remodelling of small resistance arteries in essential hypertension

High Blood Pressure and Cardiovascular Prevention

Volumn 13, Issue 1, 2006, Pages 1-6

  De Ciuceis, Carolina ^a   Rizzoni, Damiano ^a   Rosei, Claudia Agabiti ^a   Porteri, Enzo ^a   Boari, Gianluca ^a   Rosei, Enrico Agabiti ^a  

^a UNIVERSITY OF BRESCIA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

AMLODIPINE; ANGIOTENSIN 2 RECEPTOR ANTAGONIST; ANTIHYPERTENSIVE AGENT; ATENOLOL; CALCIUM ANTAGONIST; CANDESARTAN HEXETIL; CILAZAPRIL; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; ENALAPRIL; IRBESARTAN; LOSARTAN; NIFEDIPINE; PERINDOPRIL;

ARTERY RESISTANCE; BLOOD VESSEL WALL; CLINICAL FEATURE; DRUG EFFECT; ESSENTIAL HYPERTENSION; HUMAN; IN VITRO STUDY; NON INSULIN DEPENDENT DIABETES MELLITUS; PRIORITY JOURNAL; PROGNOSIS; REVIEW; SMOOTH MUSCLE FIBER; TUNICA MEDIA;

EID: 33744476709     PISSN: 11209879     EISSN: 11209879     Source Type: Journal    
DOI: 10.2165/00151642-200613010-00001     Document Type: Review

References (52)

1. Schiffrin EL. Remodeling of resistance arteries in essential hypertension and effects of antihypertensive treatment. Am J Hypertens 2004; 17: 1192-200
2. Christensen KL, Mulvany MJ. Location of resistance arteries. J Vasc Res 2001; 38: 1-12
3. Mulvany MJ. Structural abnormalities of the resistance vasculature in hypertension. J Vasc Res 2003; 40: 558-60
4. Bund SJ, Lee RMKW. Arterial structural changes in hypertension: a consideration of methodology, terminology and functional consequences. J Vasc Res 2003; 40: 547-57
5. Levy BI, Ambrosio G, Pries AR, et al. Microcirculation in hypertension: a new target for treatment? Circulation 2001; 104: 735-40
6. Antonios TF, Singer DR, Markandu ND, et al. Rarefaction of skin capillaries in borderline essential hypertension suggests an early structural abnormality. Hypertension 1999; 34 (4 Pt 1): 655-8
7. Antonios TF, Singer DR, Markandu ND, et al. Structural skin capillary rarefaction in essential hypertension. Hypertension 1999; 33 (4): 998-1001
8. Agabiti-Rosei E, Rizzoni D, Castellano M, et al. Media: lumen ratio in human small resistance arteries is related to forearm minimal vascular resistance. J Hypertens 1995; 13: 341-7
9. Aalkjaer C, Haegerty AM, Petersen KK, et al. Evidence for increased media thickness, increased neural amine uptake, and depressed excitation-contraction coupling in isolated resistance vessels from essential hypertensives. Circ Res 1987; 61 (2): 181-6
10. Heagerty AM, Aalkjaaer C, Bund SJ, et al. Small artery structure in hypertension. Dual process of remodeling and growth. Hypertension 1993; 21: 391-7
11. Rizzoni D, Porteri E, Castellano M, et al. Vascular hypertrophy and remodeling in secondary hypertension. Hypertension 1996; 28: 785-90
12. Rizzoni D, Porteri E, Guelfi D, et al. Cellular hypertrophy in subcutaneous small arteries of patients with renovascular hypertension. Hypertension 2000; 35: 931-5
13. Bakker ENTP, van der Meulen ET, van den Berg BM, et al. Inward remodeling follows chronic vasoconstriction in isolated resistance arteries. J Vasc Res 2002; 39: 12-20
14. Intengan HD, Schiffrin EL. Structure and mechanical properties of resistance arteries in hypertension: role of adhesion molecules and extracellular matrix determinants. Hypertension 2000; 36: 312-8
15. Heerkens EH, Shaw L, Izzard IS, et al. Integrins in hypertension mediate eutrophic remodeling of tgr (REN2)27 rat arteries [abstract]. Hypertension 2004; 44 (4): 49
16. Bakker ENTP, Buus CL, Spaan JAE, et al. Small artery remodeling depends on tissue-type transglutaminase. Circ Res 2005; 96: 119-26
17. Laviades C, Varo N, Fernández J, et al. Abnormalities of the extracellular degradation of collagen type I in essential hypertension. Circulation 1998; 98: 535-40
18. Intengan HD, Schiffrin EL. Vascular remodeling in hypertension: roles of apoptosis, inflammation, and fibrosis. Hypertension 2001; 38 (3 Pt 2): 581-7
19. Rizzoni D, Porteri E, Castellano M, et al. Vascular hypertrophy and remodeling in secondary hypertension. Hypertension 1996; 28: 785-90
20. Rizzoni D, Porteri E, Guelfi D, et al. Structural alterations in subcutaneous small arteries of normotensive and hypertensive patients with non insulin dependent diabetes mellitus. Circulation 2001; 103: 1238-44
21. Schofield I, Malik R, Izzard A, et al. Vascular structural and functional changes in type 2 diabetes mellitus: evidence for the role of abnormal myogenic responsiveness and dyslipidemia. Circulation 2002; 106: 3037-43
22. Endemann DH, Pu Q, De Ciuceis C, et al. Persistent remodeling of resistance arteries in type 2 diabetic patients on antihypertensive treatment. Hypertension 2004; 43: 399-404
23. Rizzoni D, Porteri E, Giustina A, et al. Acromegalic patients show the presence of hypertrophic remodeling of subcutaneous small resistance arteries. Hypertension 2004; 43: 561-5
24. Touyz RM. Oxidative stress and vascular damage in hypertension. Curr Hypertens Rep 2000; 2 (1): 98-105
25. Struijker Boudier HAJ. Microcirculation in hypertension. Eur Heart J 1999; 1 Suppl. L: L32-7
26. Lever AF. Slow pressor mechanisms in hypertension: a role for hypertrophy of resistance vessels? J Hypertens 1986; 4: 515-24
27. Korner PI, Bobik A, Jennings GL, et al. Significance of cardiovascular hypertrophy in the development and maintenance of hypertension. J Cardiovasc Pharmacol 1991; 17 Suppl. 2: S25-32
28. Schiffrin EL. Reactivity of small blood vessel in hypertension: relation with structural changes: state of the art lecture. Hypertension 1992; 19 Suppl. II: II1-9
29. Izzard AS, Heagerty AM, Leenen FHH. The amplifier hypothesis: permission to dissent? J Hypertens 1999; 17: 1667-9
30. Izzard AS, Heagerty AM, Leenen FH. The amplifier hypothesis: persisting dissent. J Hypertens 2002; 20: 375-7
31. Park JB, Schiffrin EL. Small artery remodeling is the most prevalent (earliest?) form of target organ damage in mild essential hypertension. J Hypertens 2001; 19: 921-30
32. Folkow B. Physiological aspects of primary hypertension. Physiol Rev 1982; 62: 347-504
33. Sivertsson R. The hemodynamic importance of structural vascular changes in essential hypertension. Acta Physiol Scand 1970; 343: 14-9
34. Rizzoni D, Palombo C, Porteri E, et al. Relationships between coronary vasodilator capacity and small artery remodeling in hypertensive patients. J Hypertens 2003; 21: 625-32
35. Muiesan ML, Rizzoni D, Salvetti M, et al. Structural changes in small resistance arteries and left ventricular geometry in patients with primary and secondary hypertension. J Hypertens 2002; 20: 1439-44
36. Izzard AS, Rizzoni D, Agabiti-Rosei E, et al. Small artery structure and hypertension: adaptive changes and target organ damage. J Hypertens 2005; 23 (2): 247-50
37. Rizzoni D, Porteri E, Boari GEM, et al. Prognostic significance of small artery structure in hypertension. Circulation 2003; 108 (18): 2230-5
38. Aalkjaer C, Eiskjaer H, Mulvany MJ, et al. Abnormal structure and function of isolated subcutaneous resistance vessels from essential hypertensive patients despite antihypertensive treatment. J Hypertens 1989; 7: 305-10
39. Heagerty AM, Bund SJ, Aalkjaer C. Effects of drug treatment on human resistance arteriole morphology in essential hypertension: direct evidence for structural remodelling of resistance vessels. Lancet 1988; II: 1209-13
40. Rizzoni D, Muiesan ML, Porteri E, et al. Effect of long-term antihypertensive treatment with lisinopril on resistance arteries in hypertensive patients with left ventricular hypertrophy. J Hypertens 1997; 15: 197-204
41. Sihm I, Schroeder AP, Aalkjaer C, et al. Normalization of resistance artery structure and left ventricular morphology with a perindopril-based regimen. Can J Cardiol 1994; 10 Suppl. D: 30D-2D
42. Thybo NK, Stephens N, Cooper A, et al. Effect of antihypertensive treatment on small arteries of patients with previously untreated essential hypertension. Hypertension 1995; 25 Pt 1: 474-81
43. Schiffrin EL, Deng LY, Larochelle P. Effects of a β-blocker or a converting enzyme inhibitor on resistance arteries in essential hypertension. Hypertension 1994; 23: 83-91
44. Schiffrin EL, Deng LY, Larochelle P. Progressive improvement in the structure of resistance arteries of hypertensive patients after 2 years of treatment with an angiotensin converting enzyme inhibitor: comparison with effects of a β-blocker. Am J Hypertens 1995; 8: 229-36
45. Schiffrin EL, Park JB, Integan HD, et al. Correction of arterial structure and endothelial dysfunction in human essential hypertension by the angiotensin receptor antagonist losartan. Circulation 2000; 101: 1653-9
46. Schiffrin EL, Park JB, Pu Q. Effect of crossing over hypertensive patients from a beta-blocker to an angiotensin receptor antagonist on resistance artery structure and on endothelial function. J Hypertens 2002; 20: 71-8
47. Rizzoni D, Porteri E, De Ciuceis C, et al. Effects of treatment with candesartan or enalapril on subcutaneous small resistance artery structure in hypertensive patients with NIDDM. Hypertension 2005; 45 Pt 2: 659-65
48. Schwartzkopff B, Brehm M, Mundhenke M, et al. Repair of coronary arterioles after treatment with perindopril in hypertensive heart disease. Hypertension 2000; 36: 220-5
49. Touyz RM, Schiffrin EL. Signal transduction mechanisms mediating the physiological and pathophysiological actions of angiotensin II in vascular smooth muscle cells. Pharmacol Rev 2000; 52: 639-72
50. Schiffrin EL, Deng LY. Structure and function of resistance arteries of hypertensive patients treated with a beta blocker or a calcium channel antagonist. J Hypertens 1996; 14: 1237-44
51. Schiffrin EL, Pu Q, Park JB. Effect of amlodipine compared to atenolol on small arteries of previously untreated essential hypertensive patients. Am J Hypertens 2002; 15: 105-10
52. Sihm I, Schroeder AP, Aalkjaer C, et al. Effect of antihypertensive treatment on cardiac and subcutaneous artery structure. A comparison between calcium channel blocker and thiazide-based regimens. Am J Hypertens 1998; 11: 263-71